Lead Plaintiff Deadline of February 6, 2026 in the Gauzy Ltd. (GAUZ) Securities Class Action Announced by Holzer & Holzer, LLC

(NasdaqGM:GAUZ), ATLANTA, Feb. 04, 2026 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against Gauzy Ltd. (“Gauzy” or the “Company”) (NASDAQ: GAUZ). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information regarding Gauzy's business, operations, and prospects, including allegations that: (1) three of […]

UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit

(NasdaqGM:URGN), PRINCETON, N.J., Feb. 04, 2026 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that management will present at the Guggenheim Securities Emerging Outlook: Biotech Summit to take place on February 11-12, 2026. Guggenheim Emerging Outlook: Biotech

Sunrise Realty Trust Commits to a $21.6 Million Senior Bridge Loan for the Acquisition of a Premier Ranch Property in Southern Colorado

(NASDAQ:SUNS), WEST PALM BEACH, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) — Sunrise Realty Trust, Inc. (“SUNS” or the “Company”) (Nasdaq: SUNS), a lender on the Tannenbaum Capital Group (“TCG”) Real Estate platform, today announced that it has originated, closed, and exited a $14.0 million commitment to a $21.6 million senior bridge loan to finance the

The Vita Coco Company to Report Full Year and Fourth Quarter 2025 Financial Results on February 18, 2026 and Participate in CAGNY Conference

(NASDAQ:COCO), NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) — The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or the “Company”), a leading high-growth platform of better-for-you beverage brands, today announced that it will report financial results for the full year and fourth quarter ended December 31, 2025, on Wednesday, February 18, 2026 before market

Southern Realty Trust Commits to a $21.6 Million Senior Bridge Loan for the Acquisition of a Premier Ranch Property in Southern Colorado

WEST PALM BEACH, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) — Southern Realty Trust Inc. (“SRT” or the “Company”), a lender on the Tannenbaum Capital Group (“TCG”) Real Estate platform, today announced that it has originated, closed, and exited a $7.6 million commitment to a $21.6 million senior bridge loan to finance the acquisition of the

LexisNexis Launches Tolley+ with Protege in the US

NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) — LexisNexis(R) Legal & Professional, a global leader in private, secure, authoritative legal workflow solutions, today announced the launch of Tolley+(TM) with Protege(TM) in the US, combining the trusted legacy of Tolley, the preeminent name for tax intelligence in the UK, with LexisNexis Protege. The US launch builds

OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism

(NASDAQ:OPK),(NASDAQ:ENTX), This is the third program that successfully combines Entera's oral peptide N-Tab(R) platform with OPKO's advanced protein chemistry capabilities The companies have accelerated this program and aim to file an investigational new drug (IND) application in late 2026 Injectable and oral oxyntomodulin (dual GLP-1/glucagon analog) for metabolic and fibrotic disorders advancing with initial Phase

Photronics to Report First Quarter 2026 Results on February 25, 2026

(NASDAQ:PLAB), BROOKFIELD, Conn., Feb. 04, 2026 (GLOBE NEWSWIRE) — Photronics, Inc. (Nasdaq: PLAB), a worldwide leader in photomask technologies and solutions, is scheduled to announce financial results for the first quarter of fiscal 2026 on Wednesday, February 25, 2026, before the market opens. Photronics will host a public conference call the same day at 8:30

NewAmsterdam Pharma to Present at the Guggenheim Emerging Outlook: Biotech Summit

(NasdaqGM:NAMS),(NasdaqGM:NAMSW), NAARDEN, The Netherlands and MIAMI, Feb. 04, 2026 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or

Cozeva Earns 2026 Best in KLAS for Risk Adjustment: POC and In-Home Health Assessments

SAN RAMON, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) — Cozeva, a healthcare technology company delivering a single, unified platform for value-based care, has earned the 2026 Best in KLAS distinction for Risk Adjustment: Point-Of-Care and In-Home Health Assessments in the Software and Services category. KLAS' analysis of the risk adjustment competitive landscape included in-depth interviews

Scroll to Top